Search

Population registration has been proposed for normalizing a large group of images into a common space, which is important in many clinical and research studies, such as brain development, aging, and atlas construction. Different from pairwise registration problem that aligns the target image to the reference directly, determining the reference or the hidden common space with the least bias is important in population registration. In order to decrease this bias, a lot of work takes the arithmetic mean image as the reference. However, the arithmetic mean image is usually too smooth to guide the population registration. This work presents an efficient symmetric population registration strategy for brain template construction, which defines the symmetric population center guiding population registration. This is important because the population registration problem can be translated into a series of pairwise registration problem which is easier to optimize and implement. Another prominent merit of proposed population registration algorithm is reference-free, which eliminates the reference dependency-related bias in population registration. Based on this symmetric population registration, the brain template is constructed by approximating both the population's intensity and gradient information. In addition, we also present a new measurement named with average bias for evaluating the unbiasedness of brain template. Experiments were first carried out on four synthetic images created with controllable transforms, which aim at comparing the difference between conventional method and proposed method. Further experiment is designed for reference-free validation. Finally, in real inter-subject brain data, twenty MRI T1 volumes with size 256 × 256 × 176 are used to construct a symmetric brain template with proposed population registration method. The constructed brain template has a small bias and clear brain details comparing with DARTEL.

Objective: To investigate the therapeutic efficacy of Iodine-125 ( 125 I) seeds brachytherapy to pancreatic ductal adenocarcinoma (PDAC) xenografts via multiparametric magnetic resonance imaging (MRI) analysis., Materials and Methods: Twenty mice were implanted subcutaneously with SW-1990 PDAC xenografts. The tumor-bearing mice were randomly divided into 125 I seeds group (n = 10) and blank control group (n = 10). Treatment response was monitored by diffusion-weighted magnetic resonance imaging (DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) obtained 1 day before, 14 and 60 days after treatment. Imaging results were correlated with histopathology., Results: 125 I seeds brachytherapy resulted in a significant increase in mean tumor apparent diffusion coefficient (ADC) values compared to the control at 14 and 60 days after treatment (p < 0.05). DCE-MRI showed a significant decrease in the perfusion parameters including K trans and K ep (p < 0.05). The mean ADCs within the peripheral region of the tumors were linearly proportional to the mean apoptotic cell density (p = 0.015; Spearman's coefficient = 0.945). The K trans and K ep were linearly proportional to microvessel density (MVD) (p = 0.043, 0.047; Spearman's coefficient = 0.891, 0.884)., Conclusion: 125 I seeds brachytherapy leads to effective inhibition of PDAC cell proliferation, higher degree of necrosis and necroptosis, and lower MVD. Both DW-MRI and DCE-MRI are feasible to monitor a response to 125 I seeds brachytherapy in the PDAC xenografts. This paper shows an original project concerning about a possible palliative treatment not only in a murine model (preclinical setting) but also in humans.

The classification of the breast imaging-reporting and data system (BI-RADS) based on magnetic resonance imaging (MRI) refers to the classification of the degree of lesions according to the image signs of lesions, which is usually subjective. Moreover, the benign and malignant lesions of BI-RADS 3-5 are overlapping, which is prone to unnecessary invasive treatment due to high diagnostic categories in clinical diagnosis. To address these problems, this research applied radiomics for feature extraction and fusion of T1-weighted (T1W) and dynamic contrast-enhanced (DEC) MRI. The least absolute shrinkage and selection operator (LASSO) algorithm was used to screen out the optimal feature collection of each type of MR image. Support vector machine (SVM), random forest (RF), K-nearest neighbour (KNN) and logistic regression (LR) algorithms were applied for BI-RADS 3-5 classification, based on which the benign and malignant lesions were further classified. The results showed that the classification accuracy of breast BI-RADS 3-5 by four radiomics models based on feature fusion was 81.25%, 87.50%, 78.38%, and 81.25%, respectively. Their accuracy in distinguishing the benign and malignant breast lesions was 90.91%, 93.55%, 92.73%, and 94.55%, respectively. This indicates that the combination of radiomics and machine learning correlation algorithm has a good effect on breast MRI BI-RADS classification and benign and malignant differentiation, and feature fusion can further improve the accuracy of classification prediction.

Accurate segmentation of brain gliomas (BG) is a crucial and challenging task for effective treatment planning in BG therapy. This study presents the weight loss function and dropout U‐Net with ConvNeXt block (WD‐UNeXt), which precisely segments BG from few shot MRI. The ConvNeXt block, which comprises the main body of the network, is a structure that can extract more detailed features from images. The weight loss function addresses the issue of category imbalance, thereby enhancing the network's ability to achieve more precise segmentation. The training set of BraTS2019 was used to train the network and apply it to test data. Dice similarity coefficient (DSC), sensitivity (Sen), specificity (Spec) and Hausdorff distance (HD) were used to assess the performance of the method. The experimental results demonstrate that the DSC of whole tumour, tumour core and enhancing tumour reached 0.934, 0.911 and 0.851, respectively. Sen of the sub‐regions achieved 0.922, 0.911 and 0.867. Spec and HD reached 1.000, 1.000, 1.000 and 3.224, 2.990, 2.844, respectively. Compared with the performance of state‐of‐the‐art methods, the DSC and HD of WD‐UNeXt were improved to varying degrees. Therefore, this method has considerable potential for the segmentation of BG. [ABSTRACT FROM AUTHOR]

BACKGROUND: Liver metastases is a pivotal factor of death in patients with colorectal cancer. The longitudinal data of colorectal liver metastases (CRLM) during treatment can monitor and reflect treatment efficacy and outcomes. OBJECTIVE: The objective of this study is to establish a radiomic model based on longitudinal magnetic resonance imaging (MRI) to predict chemotherapy response in patients with CRLM. METHODS: This study retrospectively enrolled longitudinal MRI data of five modalities on 100 patients. According to Response Evaluation Criteria in Solid Tumors (RECIST 1.1), 42 and 58 patients were identified as responders and non-responders, respectively. First, radiomic features were computed from different modalities of image data acquired pre-treatment and early-treatment, as well as their differences (Δ). Next, the features were screened by a two-sample t-test, max-relevance and min-redundancy (mRMR), and least absolute shrinkage and selection operator (LASSO). Then, several ensemble radiomic models that integrate support vector machine (SVM), k-nearest neighbor (KNN), gradient boost decision tree (GBDT) and multi-layer perceptron (MLP) were established based on voting method to predict chemotherapy response. Data samples were divided into training and verification queues using a ratio of 8:2. Finally, we used the area under ROC curve (AUC) to evaluate model performance. RESULTS: Using the ensemble model developed using featue differences (Δ) computed from the longitudinal apparent diffusion coefficient (ADC) images, AUC is 0.9007±0.0436 for the training cohort. Applying to the testing cohort, AUC is 0.8958 and overall accuracy is 0.9. CONCLUSIONS: Study results demonstrate advantages and high performance of the ensemble radiomic model based on the radiomics feature difference of the longitudinal ADC images in predicting chemotherapy response, which has potential to assist treatment decision-making and improve clinical outcome. [ABSTRACT FROM AUTHOR]

Objective: Alzheimer's disease (AD) is an irreversible neurodegenerative disease, while mild cognitive impairment (MCI) is a clinical precursor of AD, thus differentiation of AD, MCI and normal control (NC) from noninvasive magnetic resonance imaging (MRI) has positive clinical implications. Material and method: We utilize a 3D residual network to classify AD, MCI, and NC, and add a multiscale module to the original network to enhance the feature representation capability of the network, as well as a cross-dimensional attentional mechanism to enhance the network's attention to important brain regions. We experimentally verified that the network is more inclined to overestimate the brain age of patients in AD and MCI subgroups, thus proving that there is a high correlation between the brain age prediction task and the AD classification task. Therefore, we adopted a multi-task learning approach, using brain age prediction as a supplementary task for AD classification to reduce the risk of overfitting of the network during the training process. Results: Our method achieved 96.02% accuracy, 93.40% precision, 91.48% recall, and 92.24% F1 value in AD/MCI/NC classification. Conclusions: Ablation experiments confirmed that our proposed cross-dimensional attention and multiscale modules can improve the diagnostic performance of AD and MCI, and that multi-task learning in conjunction with brain age prediction can further improve the performance. • Multi-task learning for Alzheimer's disease classification & brain age prediction. • Cross-dimensional attention and multi-scale modules improved network performance. • Neural network heatmap reflecting key brain regions for interpretability analysis. [ABSTRACT FROM AUTHOR]

Schwannoma (SCH) and meningiomas (MEN) are the two most common primary spinal cord tumors. Differentiating between them preoperatively remains a clinical challenge due to the substantial overlap in their clinical presentation and imaging characteristics.The objective of this study is to facilitate early diagnosis of patients and reduce clinician stress by constructing a deep learning-based classification model for automatic diagnosis of schwannoma and meningiomas using magnetic resonance images (MRI).We retrospectively collected MRI images of 74 patients with pathologically confirmed schwannoma and meningiomas from 2015 to 2020 at a local hosipital, and constructed a CNN model based on the PyTorch's deep learning framework for the discrimination between the two. First, a modified feature fusion CNN model (ResNet34-SKConv) was trained by introducing a selective convolutional kernel module into the original CNN model. The introduction of the selective convolutional kernel module enhances the network's focus on tumor features and effectively improves the network's performance. Finally, the trained model was used to process all the MRI image slices to achieve the classification of SCH and MEN patients by the voting prediction method.Using the 5-fold cross-validation method, this new ResNet34-SKConv model achieves a classification accuracy of 92.32%, a specificity of 95.87%, and a F1-score of 93.54, respectively.This study demonstrated that a classification model using a deep learning network can be effective in achieving differential diagnosis of SCH and MEN. Thus, the new method has great potential for developing new computer-aided diagnosis and applications with future clinical practice. [ABSTRACT FROM AUTHOR]